AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
158 hedge funds and large institutions have $1.47B invested in Aerie Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 38 increasing their positions, 69 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
45% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 69
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Holders
158
Holding in Top 10
3
Calls
$16.7M
Puts
$8.73M
Top Buyers
| 1 | +$118M | |
| 2 | +$18.7M | |
| 3 | +$18.1M | |
| 4 |
Two Sigma Investments
New York
|
+$11.5M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$11.1M |
Top Sellers
| 1 | -$47.3M | |
| 2 | -$31.2M | |
| 3 | -$13.3M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$9.56M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$8.39M |